Wall Street Analyst Initiated Exact Sciences Corp [EXAS]. What else is Wall St. saying

MRKR Stock

Exact Sciences Corp [NASDAQ: EXAS] price plunged by -3.60 percent to reach at -$1.99.

A sum of 3888031 shares traded at recent session while its average daily volume was at 2.94M shares. Exact Sciences Corp shares reached a high of $55.46 and dropped to a low of $52.195 until finishing in the latest session at $53.32.

The one-year EXAS stock forecast points to a potential upside of 22.77. The average equity rating for EXAS stock is currently 1.43, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Exact Sciences Corp [EXAS]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EXAS shares is $69.04 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EXAS stock is a recommendation set at 1.43. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Mizuho have made an estimate for Exact Sciences Corp shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on April 10, 2025. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price to Sector Perform. The new note on the price target was released on March 13, 2025, representing the official price target for Exact Sciences Corp stock. Previously, the target price had yet another raise to $70, while Barclays analysts kept a Overweight rating on EXAS stock.

The Price to Book ratio for the last quarter was 4.20, with the Price to Cash per share for the same quarter was set at 4.17. Price to Free Cash Flow for EXAS in the course of the last twelve months was 51.81 with Quick ratio for the last quarter at 2.38.

EXAS Stock Performance Analysis:

Exact Sciences Corp [EXAS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.00. With this latest performance, EXAS shares dropped by -2.40% in over the last four-week period, additionally sinking by -7.75% over the last 6 months – not to mention a drop of -5.11% in the past year of trading.

Insight into Exact Sciences Corp Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Exact Sciences Corp [EXAS] shares currently have an operating margin of -6.75% and a Gross Margin at 69.57%. Exact Sciences Corp’s Net Margin is presently recorded at -36.06%.

Return on Equity for this stock declined to -16.87%, with Return on Assets sitting at -16.87%.

Exact Sciences Corp [EXAS] Institutonal Ownership Details

There are presently around $98.49%, or 99.40% of EXAS stock, in the hands of institutional investors. The top three institutional holders of EXAS stocks are: VANGUARD GROUP INC with ownership of 18.18 million shares, which is approximately 9.8611%. CAPITAL WORLD INVESTORS, holding 16.5 million shares of the stock with an approximate value of $$697.18 million in EXAS stocks shares; and CAPITAL WORLD INVESTORS, currently with $$624.81 million in EXAS stock with ownership which is approximately 8.0235%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.